ClassID:

97028

C07K14/705 - page 5 - CPC Classification

Classification description:

Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans Receptors; Cell surface antigens; Cell surface determinants

Recent Application in this class:
#1201
20190290767
2019-09-26

Method of reducing formation of etanercept aggregates or fragments

#1202
20190290766
2019-09-26

Stable aqueous etanercept composition

#1203
20190290765
2019-09-26

Method of Reducing Formation of Etanercept Aggregates or Fragments

#1204
20190284595
2019-09-19

Polypeptide and method of producing IMP using the same

#1205
20190284254
2019-09-19

Methods of promoting CNS neuronal repair by inhibiting LRP-1

#1206
20190284236
2019-09-19

Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

#1207
20190284235
2019-09-19

Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

#1208
20190284221
2019-09-19

Tris- or neopentyl glycol-based amphiphiles and uses thereof

#1209
20190276555
2019-09-12

TAG-72-binding chimeric antigen receptors

#1210
20190275171
2019-09-12

GENE THERAPY AND TARGETED DELIVERY OF CONJUGATED COMPOUNDS

#1211
20190275170
2019-09-12

Polynucleotides encoding JAGGED1 for the treatment of Alagille syndrome

#1212
20190275169
2019-09-12

TARGETED IMMUNOSUPPRESSION FOR OPTOGENETIC INTERVENTION

#1213
20190275128
2019-09-12

Use of toll-like receptor agonist for treating cancer

#1214
20190275126
2019-09-12

PEPTIDE

#1215
20190275118
2019-09-12

Agents directed against a cis RGMa/neogenin interaction or lipid rafts and use of the same in methods of treatment

#1216
20190274291
2019-09-12

Transferrin receptor transgenic models

#1217
20190270806
2019-09-05

IL-6 antibodies and fusion constructs and conjugates thereof

#1218
20190269770
2019-09-05

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

#1219
20190269767
2019-09-05

Peptides and combination of peptides for use in immunotherapy against various cancers

#1220
20190269729
2019-09-05

Modified natural killer cells for the treatment of cancer

#1221
20190265231
2019-08-29

GPCR (GPR113) INVOLVED IN FAT, FATTY ACID AND/OR LIPID-ASSOCIATED TASTE AND USE IN ASSAYS FOR IDENTIFYING TASTE MODULATORY

#1222
20190263902
2019-08-29

Modified membrane spanning proteins and methods for the preparation and use thereof

#1223
20190263885
2019-08-29

Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)

#1224
20190263884
2019-08-29

Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)

#1225
20190263883
2019-08-29

METHOD FOR AUGMENTING VISION IN PERSONS SUFFERING FROM PHOTORECEPTOR CELL DEGENERATION

#1226
20190263863
2019-08-29

Polypeptide and use thereof

#1227
20190262444
2019-08-29

Peptides and combination of peptides for use in immunotherapy against various cancers

#1228
20190256571
2019-08-22

Compositions and methods for TCR reprogramming using fusion proteins

#1229
20190255107
2019-08-22

Modulation of novel immune checkpoint targets

#1230
20190255082
2019-08-22

Enhancement of CD47 blockade therapy by proteasome inhibitors

#1231
20190249191
2019-08-15

Multimeric coding nucleic acid and uses thereof

#1232
20190248902
2019-08-15

Methods of treating cardiovascular disease with an anti-ASGR antibody or binding fragments thereof

#1233
20190248894
2019-08-15

Bi-specific molecule for cell-specific Notch inhibition and related methods and compositions

#1234
20190248864
2019-08-15

POLYNUCLEOTIDES ENCODING LOW DENSITY LIPOPROTEIN RECEPTOR

#1235
20190248862
2019-08-15

Methods and compositions for treating cancer

#1236
20190248855
2019-08-15

Modified cystic fibrosis transmembrane conductance regulator (CFTR) polypeptides with increased stability and uses thereof

#1237
20190248833
2019-08-15

METHODS FOR REDUCING CD36 EXPRESSION

#1238
20190241925
2019-08-08

Cell-associated secretion-enhancing fusion proteins

#1239
20190241597
2019-08-08

Mesitylene-cored amphiphiles and uses thereof

#1240
20190240351
2019-08-08

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS

#1241
20190233501
2019-08-01

Methods and compositions relating to covalently circularized nanodiscs

#1242
20190231819
2019-08-01

Slit2D2-chimeric antigen receptor and application thereof

#1243
20190231817
2019-08-01

Methods of generating T-cells from stem cells and immunotherapeutic methods using the T-cells

#1244
20190225667
2019-07-25

Inducible caspases and methods for use

#1245
20190225659
2019-07-25

Odorant receptor co-receptor

#1246
20190224340
2019-07-25

Materials and methods for treatment of pain related disorders

#1247
20190224296
2019-07-25

Toll-like receptor 2 agonists and vaccines and uses thereof

#1248
20190219566
2019-07-18

Method for identifying modulators of notch signaling

#1249
20190218298
2019-07-18

Neutralizing antibodies to the αvβ8 integrin complex for immunotherapy

#1250
20190218273
2019-07-18

Nucleic acid encoding angiopoietin-2 specific Tie2 receptor

#1251
20190218272
2019-07-18

ALK4:ACTRIIB HETEROMULTIMERS AND USES THEREOF

#1252
20190218271
2019-07-18

Mutant light-inducible ion channel of chrimson

#1253
20190218256
2019-07-18

MUTANT LIGHT-INDUCIBLE ION CHANNEL OF CHANNELRHODOPSIN

#1254
20190216941
2019-07-18

Transduction

#1255
20190216930
2019-07-18

Etanercept formulations stabilized with amino acids

#1256
20190216890
2019-07-18

Compositions, methods and uses comprising teneurin C-terminal associated peptide -1 (TCAP-1) for enhancing muscle performance

#1257
20190216851
2019-07-18

Modified cell expansion and uses thereof

#1258
20190211369
2019-07-11

Protein production in microorganisms of the phylum labyrinthulomycota

#1259
20190209670
2019-07-11

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

#1260
20190202918
2019-07-04

Proteolytically cleavable chimeric polypeptides and methods of use thereof

#1261
20190202915
2019-07-04

Method of altering an antibody-related adverse event based on SCD163 and/or CXCL5 levels

#1262
20190202913
2019-07-04

Chimeric antigen receptors targeting CD-19

#1263
20190202891
2019-07-04

GPR156 variants and uses thereof

#1264
20190202886
2019-07-04

ONCOLYTIC VIRUSES COMPRISING esRAGE AND METHODS OF TREATING CANCER

#1265
20190202885
2019-07-04

TauT (taurine transporter) peptide cancer vaccine

#1266
20190202880
2019-07-04

Adeno-associated virus vector delivery of B-sarcoglycan and microrna-29 and the treatment of muscular dystrophy

#1267
20190201539
2019-07-04

Synthetic compound

#1268
20190201443
2019-07-04

Signaling and antigen-presenting bifunctional receptors (SABR)

#1269
20190194753
2019-06-27

Methods and compositions for screening and treating developmental disorders

#1270
20190194615
2019-06-27

T cell compositions

#1271
20190194333
2019-06-27

KLRG1 DEPLETION THERAPY

#1272
20190194320
2019-06-27

METHODS OF IDENTIFYING EPITOPES

#1273
20190194314
2019-06-27

ANTIBODIES FOR MODULATING BINDING BETWEEN LRP AND WISE

#1274
20190194294
2019-06-27

Agent for restoring visual function or agent for preventing deterioration in visual function

#1275
20190194287
2019-06-27

Methods and compositions for treating diseases and disorders of the nervous system

#1276
20190194286
2019-06-27

Method of manufacturing membrane protein and utilization thereof

#1277
20190194246
2019-06-27

SOLID PHASE PEPTIDE SYNTHESIS

#1278
20190187158
2019-06-20

Methods for increasing palatability of pet foodstuff

#1279
20190184054
2019-06-20

COMPOSITIONS FOR THE TREATMENT OF PAIN AND/OR INFLAMMATION

#1280
20190184017
2019-06-20

Etanercept formulations stabilized with xylitol

#1281
20190183997
2019-06-20

IDENTIFICATION AND PRODUCTION OF HIGH AFFINITY IGM ANTIBODIES AND DERIVATIVES THEREOF

#1282
20190183975
2019-06-20

Human Notch1 based fusion proteins as decoy inhibitors of jagged-notch signaling and DLL-notch signaling

#1283
20190183833
2019-06-20

Compounds for the treatment of neuromuscular disorders

#1284
20190177410
2019-06-13

Fusion protein comprising apelin and an anti-APLNR antibody

#1285
20190177394
2019-06-13

DSG2-derived peptides

#1286
20190177383
2019-06-13

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#1287
20190175689
2019-06-13

Chloride salt of TAT-NR2B9c

#1288
20190170772
2019-06-06

Methods for identifying modulators of GPR92

#1289
20190169669
2019-06-06

PHEROMONAL RECEPTOR OF SPODOPTERA LITTORALIS AND IDENTIFICATION OF NATURAL LIGAND OF SAID RECEPTOR AND USES THEREOF

#1290
20190169259
2019-06-06

BTNL3 proteins, nucleic acids and antibodies and uses thereof

#1291
20190167576
2019-06-06

USE OF HIGH AFFINITY MONOCLONAL ANTIBODY PRODUCT BINDERS TO INCREASE THE DURATION OF ACTION OF THERAPEUTIC MONOCLONAL ANTIBODY PRODUCTS IN A BIOLOGIC TISSUE

#1292
20190161529
2019-05-30

Compositions and methods for neurological diseases

#1293
20190161528
2019-05-30

CLAUDIN-6 PEPTIDES

#1294
20190153540
2019-05-23

Biomarkers for non-hodgkin lymphomas and uses thereof

#1295
20190153496
2019-05-23

Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins

#1296
20190153477
2019-05-23

Materials and methods for treatment of pain related disorders

#1297
20190153445
2019-05-23

Composition for delivery of genetic material

#1298
20190153061
2019-05-23

Anti-BCMA chimeric antigen receptor

#1299
20190151428
2019-05-23

Vaccine compositions comprising an amphipathic compound, a neoantigen and a hydrophobic carrier, and methods of use thereof

#1300
20190151406
2019-05-23

Lipopeptides for use in treating liver diseases and cardiovascular diseases

#1301
20190144522
2019-05-16

Anti-CD7 chimeric antigen receptor and method of use thereof

#1302
20190142935
2019-05-16

Formulation containing TLR agonist and methods of use

#1303
20190142898
2019-05-16

Peptides of syndecan-1 for inhibiting angiogenesis

#1304
20190142896
2019-05-16

Methods and compositions for the treatment of radiation-related disorders

#1305
20190142752
2019-05-16

Stable nanolipoprotein particles and related compositions methods and systems

#1306
20190137496
2019-05-09

Modified multispanning membrane polypeptides and methods of use thereof to screen therapeutic agents

#1307
20190134093
2019-05-09

Systems and methods for targeting cancer cells

#1308
20190127718
2019-05-02

SUPPRESSION OF CANCER

#1309
20190127439
2019-05-02

Engineered PD-1 variants

#1310
20190127434
2019-05-02

Method for producing TLR5 agonist protein

#1311
20190125871
2019-05-02

DEVICES, SYSTEMS AND METHODS FOR OPTOGENETIC MODULATION OF ACTION POTENTIALS IN TARGET CELLS

#1312
20190119379
2019-04-25

Cancer gene therapy targeting CD47

#1313
20190119349
2019-04-25

PAR3 mimetic peptides and uses thereof

#1314
20190119343
2019-04-25

Artificial synapse inducer and method of making the same

#1315
20190119339
2019-04-25

NOVEL HUMAN ULIP/CRMP PROTEIN AND USE THEREOF IN DIAGNOSIS AND TREATMENT OF CANCERS AND PARANEOPLASTIC NEUROLOGICAL SYNDROMES

#1316
20190117793
2019-04-25

MODULAR NANODEVICES FOR SMART ADAPTABLE VACCINES

#1317
20190117785
2019-04-25

PAR2 mimetic peptides and uses thereof

#1318
20190117751
2019-04-25

TUMOR ANTIGEN PEPTIDE

#1319
20190117749
2019-04-25

PEPTIDE VACCINE THERAPY FOR TREATMENT OF FRa-EXPRESSING TUMORS

#1320
20190117729
2019-04-25

GJA1 isoforms protect against metabolic stress

#1321
20190112597
2019-04-18

Biosensors for chloride ions

#1322
20190112355
2019-04-18

Stable proteins

#1323
20190112301
2019-04-18

ACTIVATION OF TRPV4 ION CHANNEL BY PHYSICAL STIMULI AND CRITICAL ROLE FOR TRPV4 IN ORGAN-SPECIFIC INFLAMMATION AND ITCH

#1324
20190111153
2019-04-18

Compositions and methods to program therapeutic cells using targeted nucleic acid nanocarriers

#1325
20190111135
2019-04-18

Compositions and their use for controlling the nervous system in vivo

#1326
20190111080
2019-04-18

Polypeptide compositions comprising spacers

#1327
20190111061
2019-04-18

Compositions and methods targeting HCN channels for breathing therapeutics

#1328
20190111032
2019-04-18

Calcium sensing receptors, ligands, compositions, and methods of use

#1329
20190100570
2019-04-04

ALK4:ActRIIB heteromultimers and uses thereof

#1330
20190094247
2019-03-28

METHODS FOR SCREENING FOR BINDING PARTNERS OF G-PROTEIN COUPLED RECEPTORS

#1331
20190094230
2019-03-28

Methods and systems for producing nanolipoprotein particles

#1332
20190094227
2019-03-28

Disease-associated antigens and methods of use thereof

#1333
20190092824
2019-03-28

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#1334
20190092816
2019-03-28

Stapled peptides and uses thereof

#1335
20190092812
2019-03-28

Cyclic peptide conjugates and methods of use

#1336
20190091315
2019-03-28

Immunity-inducing agent

#1337
20190091314
2019-03-28

Peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers

#1338
20190091313
2019-03-28

Peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers

#1339
20190086393
2019-03-21

In vitro methods of detecting heteroligomeric T1R2/T2R3-expressing cells that are potentially sensitive to sweet tastants

#1340
20190085051
2019-03-21

TIR taste receptors and genes encoding same

#1341
20190083652
2019-03-21

Using DREADD for neuronal modulation in treating neuronal diseases

#1342
20190083651
2019-03-21

AAV-MEDIATED SUBCELLULAR TARGETING OF HETEROLOGOUS RHODOPSINS IN RETINAL GANGLION CELLS

#1343
20190083540
2019-03-21

Compositions and methods related to multimodal therapeutic cancer indications

#1344
20190079074
2019-03-14

Step-function channelrhodopsins for optical control of cells

#1345
20190078099
2019-03-14

CELL LINE FOR RECOMBINANT PROTEIN AND/OR VIRAL VECTOR PRODUCTION

#1346
20190077832
2019-03-14

Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

#1347
20190076514
2019-03-14

Peptides and combination of peptides for use in immunotherapy against NHL and other cancers

#1348
20190076513
2019-03-14

Peptides and combination of peptides for use in immunotherapy against NHL and other cancers

#1349
20190076492
2019-03-14

Immunity-inducing agent

#1350
20190071517
2019-03-07

Antibody binding to HEG1 and use of the antibody for detection and treatment of mesothelioma

#1351
20190071468
2019-03-07

PEPTIDE INHIBITORS OF SODIUM CHANNELS

#1352
20190070279
2019-03-07

Peptides and combination of peptides for use in immunotherapy against NHL and other cancers

#1353
20190066489
2019-02-28

Configuring a smart home controller

#1354
20190062450
2019-02-28

Engineered antigen presenting cells and uses thereof

#1355
20190062389
2019-02-28

Peptide derived from GPC3, pharmaceutical composition for treatment or prevention of cancer using same, immunity inducer, and method for producing antigen-presenting cells

#1356
20190062380
2019-02-28

Fusion proteins for promoting an immune response, nucleic acids encoding same, and methods of making and use thereof

#1357
20190060430
2019-02-28

Antigen-specific T cell receptors and T cell epitopes

#1358
20190056396
2019-02-21

EXPRESSION CONSTRUCTS AND METHODS FOR SELECTING HOST CELLS EXPRESSING POLYPEPTIDES

#1359
20190055521
2019-02-21

Methods of propagating rhinovirus C in previously unsusceptible cell lines

#1360
20190055312
2019-02-21

Binding members to PD-L1

#1361
20190055297
2019-02-21

Use of gene editing to generate universal TCR re-directed T cells for adoptive immunotherapy

#1362
20190054188
2019-02-21

Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor

#1363
20190049469
2019-02-14

BIOMARKER FOR USE IN TREATING ANEMIA

#1364
20190049463
2019-02-14

Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof

#1365
20190049462
2019-02-14

LIGHT-ACTIVATED CATION CHANNEL AND USES THEREOF

#1366
20190049430
2019-02-14

OMA1 activity assay

#1367
20190048085
2019-02-14

MODIFIED CELLS FOR IMMUNOTHERAPY

#1368
20190048074
2019-02-14

Method for treating pathological angiogenesis by administering an antibody that inhibits APLNR

#1369
20190048062
2019-02-14

Recombinant chimeric protein for selectins targeting

#1370
20190048057
2019-02-14

Compositions comprising TREM2 and methods of use thereof

#1371
20190046662
2019-02-14

Compositions and Methods for Treating Neuropathic Pain

#1372
20190041400
2019-02-07

PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF

#1373
20190040157
2019-02-07

Polypeptide selectively binding to immunoglobulin G of mouse or rabbit and use thereof

#1374
20190040128
2019-02-07

Nucleic acids encoding lectin-like oxidized LDL receptor 1 antibodies

#1375
20190030072
2019-01-31

Cell derived extracellular vesicles for the treatment of diseases

#1376
20190023782
2019-01-24

Anti-PD-1 antibody and use thereof

#1377
20190023765
2019-01-24

Method for producing erythrocyte proteins

#1378
20190023756
2019-01-24

EPHA2 t-cell epitope agonists and uses therefore

#1379
20190022249
2019-01-24

Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor

#1380
20190022121
2019-01-24

Modulators of zinc activated cation channel

#1381
20190018001
2019-01-17

NUCLEIC ACIDS ENCODING A G-PROTEIN COUPLED RECEPTOR INVOLVED IN SENSORY TRANSDUCTION

#1382
20190017068
2019-01-17

Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor

#1383
20190016775
2019-01-17

Immunogenic Compositions

#1384
20190016768
2019-01-17

EGF(A) analogues with fatty acid substituents

#1385
20190015527
2019-01-17

Adeno-associated virus (AAV) clades, sequences, vectors containing same, and uses therefor

#1386
20190015492
2019-01-17

Peptides and combination of peptides for use in immunotherapy against various cancers

#1387
20190015477
2019-01-17

MUTEINS OF TEAR LIPOCALIN AND METHODS FOR OBTAINING THE SAME

#1388
20190015451
2019-01-17

Chimeric protein

#1389
20190014756
2019-01-17

Human ARCAP transgenic mouse

#1390
20190010532
2019-01-10

Overexpression of N-glycosylation pathway regulators to modulate glycosylation of recombinant proteins

#1391
20190010245
2019-01-10

Synthetic protein for modulating gene expression

#1392
20190010240
2019-01-10

Composition comprised of antigen linked to a TNF superfamily ligand

#1393
20190010220
2019-01-10

Conditionally active chimeric antigen receptors for modified t-cells

#1394
20190010210
2019-01-10

Targeted expression of chloride channels and methods of use thereof

#1395
20190008940
2019-01-10

Nucleic acid molecules encoding for chimeric CSPG4 proteins and therapeutic uses thereof

#1396
20190004032
2019-01-03

Genetically encoded red fluorescent voltage sensors enabling millivolt-resolution and high-speed neural voltage imaging

#1397
20190002917
2019-01-03

Gene therapy for treating familial hypercholesterolemia

#1398
20190002913
2019-01-03

PROMOTERS, EXPRESSION CASSETTES, VECTORS, KITS, AND METHODS FOR THE TREATMENT OF ACHROMATOPSIA AND OTHER DISEASES

#1399
20190002527
2019-01-03

Methods and compositions for the inhibition of TRPV4

#1400
20190002521
2019-01-03

Therapeutic agents

#1401
20190002502
2019-01-03

Cell-permeable inhibitory agent and methods of use thereof in treatment of cognitive and mood disorders

#1402
20180372762
2018-12-27

Calcium indicator polypeptides and methods of use thereof

#1403
20180371049
2018-12-27

HIGH AFFINITY NY-ESO T CELL RECEPTORS

#1404
20180369374
2018-12-27

MRNA combination therapy for the treatment of cancer

#1405
20180369352
2018-12-27

Vectors for expression of prostate-associated antigens

#1406
20180369280
2018-12-27

High affinity T cell receptors and uses thereof

#1407
20180362935
2018-12-20

A renal cell line with stable transporter expression

#1408
20180362651
2018-12-20

Methods and antibodies for modulation of immunoresponse

#1409
20180362623
2018-12-20

Methods and compositions for promoting thermogenic potential

#1410
20180362603
2018-12-20

Methods and compositions for reducing the immunogenicity of chimeric notch receptors

#1411
20180360995
2018-12-20

MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF COSMETIC PROTEINS AND PEPTIDES

#1412
20180360937
2018-12-20

Peptides and combination of peptides for use in immunotherapy against various cancers

#1413
20180360936
2018-12-20

Peptides and combination of peptides for use in immunotherapy against various cancers

#1414
20180355052
2018-12-13

Compositions and methods for treating cancer with anti-CD19/CD20 immunotherapy

#1415
20180355037
2018-12-13

Anti-human ADRB3 monoclonal antibody and application thereof in disease diagnosis and treatment

#1416
20180355018
2018-12-13

Compounds for treating neurodegenerative proteinopathies

#1417
20180355014
2018-12-13

Modified chimeric receptors and related compositions and methods

#1418
20180355011
2018-12-13

Binding-triggered transcriptional switches and methods of use thereof

#1419
20180353619
2018-12-13

Gene therapy for the treatment of a disease of retinal cone cells

#1420
20180353605
2018-12-13

Ferritin nanoparticle compositions and methods to modulate cell activity

#1421
20180348227
2018-12-06

Cancer antigen targets and uses thereof

#1422
20180346998
2018-12-06

Mutations in rhodopsin gene in zebrafish and uses thereof

#1423
20180346589
2018-12-06

Synthetic notch protein for modulating gene expression

#1424
20180346575
2018-12-06

PEPTIDES

#1425
20180346540
2018-12-06

Monomeric and Dimeric Forms of Adiponectin Receptor Fragments and Methods of Use

#1426
20180346538
2018-12-06

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#1427
20180344829
2018-12-06

Siglec-10 antibodies

#1428
20180344826
2018-12-06

Peptides and combination of peptides and scaffolds for use in immunotherapy against Renal Cell Carcinoma (RCC) and other cancers

#1429
20180344823
2018-12-06

Use of toll-like receptor agonist for treating cancer

#1430
20180340187
2018-11-29

Methods of treating muscular dystrophy

#1431
20180340026
2018-11-29

ROR1 antibody compositions and related methods

#1432
20180340021
2018-11-29

Conditionally active chimeric antigen receptors for modified T-cells

#1433
20180335429
2018-11-22

Methods to spatially profile protease activity in tissue and sections

#1434
20180335422
2018-11-22

Transformed cell lines expressing non-endogenous cell-surface selective guanosine-responsive G-protein coupled receptors

#1435
20180334653
2018-11-22

Transgenic macrophages, chimeric antigen receptors, and associated methods

#1436
20180333456
2018-11-22

OPTICALLY-CONTROLLED CNS DYSFUNCTION

#1437
20180333455
2018-11-22

Method for modulating insulin-independent glucose transport using teneurin C-terminal associated peptide (TCAP)

#1438
20180328944
2018-11-15

Light-activated cation channel and uses thereof

#1439
20180328916
2018-11-15

toxin receptors and uses thereof

#1440
20180327780
2018-11-15

CYP-P22 biocatalytic nanoparticles with cytochrome P450 activity for prodrug activation

#1441
20180327768
2018-11-15

TARGETED DELIVERY OF THERAPEUTIC PROTEINS BIOENCAPSULATED IN PLANT CELLS TO CELL TYPES OF INTEREST FOR THE TREATMENT OF DISEASE

#1442
20180327752
2018-11-15

Methods and compositions for modulating AAV infection

#1443
20180327726
2018-11-15

Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods

#1444
20180325796
2018-11-15

FUNCTIONAL REGULATORY ANTIBODY HAVING ACTIONS OF PROMOTING PROLIFERATION, SURVIVAL, AND CELL ACTIVATION OF DERMAL PAPILLA CELLS AS HAIR GROWTH REGULATING CENTER CELLS AND USE THEREOF

#1445
20180319882
2018-11-08

PLEXIN D1 AS A TARGET FOR TUMOR DIAGNOSIS AND THERAPY

#1446
20180319870
2018-11-08

Methods to create chemically-induced dimerizing protein systems for regulation of cellular events

#1447
20180319847
2018-11-08

Compositions and methods for treating conditions related to ephrin signaling with Cupredoxins

#1448
20180318451
2018-11-08

PSMA-specific binding proteins

#1449
20180312816
2018-11-01

Host cells and systems for membrane protein expression

#1450
20180312566
2018-11-01

Fc FUSION HIGH AFFINITY IgE RECEPTOR ALPHA-CHAIN

#1451
20180312562
2018-11-01

WATER SOLUBLE MEMBRANE PROTEINS AND METHODS FOR THE PREPARATION AND USE THEREOF

#1452
20180311381
2018-11-01

Modified Polynucleotides for the production of biologics and proteins associated with human disease

#1453
20180311348
2018-11-01

Trispecific molecule combining specific tumor targeting and local immune checkpoint inhibition

#1454
20180311176
2018-11-01

Nanoparticle formulations for delivery of nucleic acid complexes

#1455
20180306789
2018-10-25

T cell receptors and immune therapy using the same

#1456
20180305452
2018-10-25

Chimeric antigen receptors and methods of use

#1457
20180305419
2018-10-25

Polypeptides and antibodies to treat skin conditions associated with overproduction of sebum

#1458
20180303901
2018-10-25

Notch1 Decoy Antagonists Protect From Obesity-Induced Insulin Resistance and Fatty Liver

#1459
20180299470
2018-10-18

Biosensors for cellular osmolarity

#1460
20180298109
2018-10-18

POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICS

#1461
20180298069
2018-10-18

Cell lines for screening odorant and aroma receptors

#1462
20180296673
2018-10-18

Anti-podocalyxin antibodies and methods of using the same

#1463
20180291105
2018-10-11

Anti-Tie2 antibodies and uses thereof

#1464
20180291090
2018-10-11

ANTAGONIST ANTI-NOTCH3 ANTIBODIES AND THEIR USE IN THE PREVENTION AND TREATMENT OF NOTCH3-RELATED DISEASES

#1465
20180291081
2018-10-11

High-affinity and soluble PDL-1 molecule

#1466
20180289742
2018-10-11

Method for preparing genetically-modified T cells which express chimeric antigen receptor

#1467
20180282403
2018-10-04

AGENTS FOR REDUCING THE ACTIVITY OF GDF15

#1468
20180282389
2018-10-04

Claudin-18.2-specific immunoreceptors and T cell epitopes

#1469
20180280489
2018-10-04

ENGINEERED LISTERIA AND METHODS OF USE THEREOF

#1470
20180280440
2018-10-04

In vitro production of red blood cells with sortaggable proteins

#1471
20180275119
2018-09-27

METHODS AND DEVICES FOR DETECTING PROTEIN IN SALIVA SAMPLES

#1472
20180274032
2018-09-27

Genetic Variants Underlying Human Cognition and Methods of Use Thereof as Diagnostic and Therapeutic Targets

#1473
20180273980
2018-09-27

Chimeric proteins and methods of regulating gene expression

#1474
20180273976
2018-09-27

Activation of taste receptor genes in mammalian cells using CRISPR-Cas-9

#1475
20180273613
2018-09-27

Humanized or affinity-matured anti ang-2 antibody and uses thereof

#1476
20180267051
2018-09-20

Method of Identifying Transmembrane Protein-interacting Compounds

#1477
20180265591
2018-09-20

METHODS AND COMPOSITIONS FOR DIAGNOSING AND TREATING DISEASES

#1478
20180265580
2018-09-20

Methods of treating cancer with a P2X7 peptide

#1479
20180265564
2018-09-20

Method for producing soluble FcR as Fc-fusion with inert immunoglobulin Fc-region and uses thereof

#1480
20180265563
2018-09-20

Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)

#1481
20180265562
2018-09-20

Consumable cryopreserved cells transiently overexpressing gene(s) encoding drug transporter protein(s) and/or drug metabolizing enzyme(s)

#1482
20180264129
2018-09-20

Core constructs and their uses in configuring pharmaceutical molecules

#1483
20180264075
2018-09-20

Use of a cyclic tripeptide for improving cellular energy metabolism

#1484
20180256753
2018-09-13

Therapeutical tools and methods for treating blindness by targeting photoreceptors

#1485
20180256743
2018-09-13

Tumor marker for the rhabdomyosarcoma

#1486
20180256693
2018-09-13

Peptides and combination of peptides and scaffolds for use in immunotherapy against renal cell carcinoma (RCC) and other cancers

#1487
20180251839
2018-09-06

Compositions and Methods for the Diagnosis of Retinal Neovascularization

#1488
20180251560
2018-09-06

Fusion immunomodulatory proteins and methods for making same

#1489
20180251546
2018-09-06

Mesothelin-targeted chimeric antigen receptors and methods of making them

#1490
20180251545
2018-09-06

Methods of treating eye disorders with APLNR antagonists and VEGF inhibitors

#1491
20180251544
2018-09-06

ANTI-HUMAN FOLATE RECEPTOR BETA ANTIBODIES AND METHODS OF USE

#1492
20180251506
2018-09-06

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#1493
20180250338
2018-09-06

Tumor infiltrating lymphocytes for treatment of cancer

#1494
20180250335
2018-09-06

MODIFIED CELLS EVOKING REDUCED IMMUNOGENIC RESPONSES

#1495
20180249689
2018-09-06

Method of using mouse having a humanized cluster of differentiation 47 gene

#1496
20180249650
2018-09-06

Soybean ROD1 gene sequences and uses thereof

#1497
20180245032
2018-08-30

Cell support composite and method for producing cell support composite

#1498
20180244769
2018-08-30

P2X7 receptor antagonists and agonists

#1499
20180244745
2018-08-30

EPHA3 and multi-valent targeting of tumors

#1500
20180243368
2018-08-30

Molecular signature of cancer